Bio
Dr. Kimberly Chapman is a Clinical and Clinical Biochemical Genetics at Children’s Hospital Los Angeles, where she currently serves as the Chief of the Metabolism Section in the Division of Medical Genetics. Originally from Omaha Nebraska, Dr. Chapman earned her undergraduate degrees in biology and chemistry from Saint Louis University. She then pursued both a PhD and MD from the University of Nebraska. Following this, she completed an Internal Medicine-Pediatric residence at the University of Pittsburgh Health Sciences Center, obtaining boar certifications in both specialties. Dr. Chapman further specialized by completing a Clinical Genetics Residency and Clinical Biochemical Genetics Fellowship at Children’s Hospital of Philadelphia/University of Pennsylvania. Before joining CHLA, she spent several years at Children’s National in Washington, DC. Dr. Chapman is renowned for her expertise in treating and developing clinical guidelines for the propionate pathway disorders and homocystinurias. She is passionate about using the latest guidelines and therapeutics to help patients with inborn errors of metabolism thrive.
"Treatment Guidelines"
For families living with Classical Homocystinuria (HCU), understanding the established standards of care is the foundation for preventing long-term complications. In this essential session, Dr. Kimberly Chapman, a leading metabolic specialist and contributor to the E-HOD (European Network and Registry for Homocystinurias and Methylation Defects) guidelines, breaks down the current management protocols for patients and caregivers. Dr. Chapman will translate complex medical guidelines into actionable knowledge, focusing on the lifelong strategies required to maintain metabolic stability.
